Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock
VS

Stock highlights

Stock comparison highlights
Stock name
Eli LillyRoche Holding
Last price
$1,354.00CHF 388.30
Currency
USD
CHF
$1.2TCHF 312B
43.9425.32
$30.81CHF 15.33
0.390.33
$6.69CHF 9.80
0.51%2.52%
Sector
HealthHealth
Employees
50,000103,249
Ticker
$LLYFr. ROP
Primary listing
NYSEXSWX

Performance

CumulativeRolling yearsLump sum investment

Invest in $LLY or Fr.ROP on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.